Executive Editor, US Policy and Regulatory, The Pink Sheet, United States
Nielsen Hobbs has more than 25 years of experience covering the pharmaceutical industry, and writes frequently about the intersection of business, regulation, science and politics. Before joining the “The Pink Sheet” he worked for Congressional Quarterly. Hobbs enjoys discussing...
Read More →SM
Medical Director, Norwegian Medicines Agency
Dr. Steinar Madsen is medical director at the Norwegian Medicines Agency. He has been working with the safe and cost-effective use of generics and biosimilars for almost 20 years. He is a specialist in internal medicine and cardiology and works part time as a consultant in cardio...
Read More →
Executive Director, Biosimilars Global Value Access & Policy, Amgen Inc.
Chad Pettit is the Executive Director Global Value Access and Policy for Amgen’s Biosimilars Business Unit with responsibility for market access launch strategy for the full Amgen portfolio of biosimilar products. Chad also serves as the Amgen board member on the Biosimilars Forum...
Read More →